Researchers at Baylor College of Medicine and collaborating institutions have uncovered new potential therapeutic targets for cancer and new insights into existing cancer drug targets, expanding the ...

MimiVax, Inc. is developing immunotherapeutic vaccines and targeted therapies for treating cancers and preventing recurrence. The company’s lead agent, SurVaxM, targets survivin, a cell-survival ...

Doctors are seeing colon cancer in people in their 20s and 30s. New research suggests it starts in infancy.

Tom Hanson is a national investigative correspondent for CBS News and Stations. His in-depth reports air across all platforms and programs. He is a member of CBS News and Stations Medical, Health, and ...

Agreement creates strong synergies between CureVac's unique end-to-end mRNA capabilities and MD Anderson's translational and clinical research expertise Collaboration aims to develop novel, ...

Survivors of breast cancer are at significantly higher risk of developing second cancers, including endometrial and ovarian cancer for women and prostate cancer for men, according to new research ...

BOSTON - A new study finds that people with breast cancer are more likely to develop a second cancer over time. Researchers at the University of Cambridge analyzed data on more than 583,000 female and ...

Researchers at MIT’s CSAIL division, which focuses on computer engineering and AI development, built two machine learning algorithms that can detect pancreatic cancer at a higher threshold than ...

Recognizing the urgent need for treatment options and guided by patient insights, Pfizer scientists have discovered a way to decrease the level of GDF-15 circulating in the body in order to ...